{
  "abstract": "Purpose: To evaluate clinical outcomes of trimethoprim-sulfamethoxazole (TMP-SMX) with or without adjunctive caspofungin in patients with moderate-to-severe human immunodeficiency virus (HIV)-associated Pneumocystis jirovecii pneumonia (PJP), and explore factors associated with poor outcomes.\n\nPatients and Methods: Patients with HIV-associated PJP admitted to Beijing Youan Hospital from July 2020 to June 2026 were retrospectively included. Moderate-to-severe PJP was defined as arterial partial pressure of oxygen <70 mmHg or alveolar-arterial oxygen gradient ≥35 mmHg on room air. Patients were grouped by regimen: TMP-SMX monotherapy or TMP-SMX plus caspofungin. The primary outcome was a composite of poor outcomes, including in-hospital death or discharge against medical advice due to poor prognosis. Between-group comparisons, a clinically specified multivariable logistic regression model, and a stabilized inverse probability of treatment weighting (IPTW) sensitivity analysis were performed.\n\nResults: Among 673 screened patients, 155 with moderate-to-severe HIV-associated PJP were analyzed after excluding mild cases and those with incomplete data; 78 received TMP-SMX monotherapy and 77 received TMP-SMX plus caspofungin. The combination group had longer hospital stays (P = 0.003) and higher procalcitonin levels (P = 0.044). Poor outcomes did not differ significantly between groups (P = 0.129). In the primary multivariable model adjusted for PaO2 on room air and C-reactive protein (CRP), adjunctive caspofungin was not significantly associated with poor outcome (adjusted odds ratio [aOR] = 1.603, 95% confidence interval [CI]: 0.654–3.925, P = 0.302). Lower PaO2 (aOR = 0.958, 95% CI: 0.921–0.996, P = 0.032) and higher CRP (aOR = 1.009, 95% CI: 1.000–1.019, P = 0.047) were associated with poor outcome. The IPTW sensitivity analysis likewise showed no statistically significant association between adjunctive caspofungin and poor outcome (weighted OR = 1.939, 95% CI: 0.790–4.763, P = 0.148).\n\nConclusion: In this retrospective cohort, no statistically significant association was detected between TMP-SMX plus adjunctive caspofungin and poor outcomes in patients with moderate-to-severe HIV-associated PJP. Lower PaO2 and higher CRP were associated with poor outcome in an exploratory adjusted analysis. Larger prospective multicenter studies are needed to clarify the role of adjunctive caspofungin.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Respiratory and Critical Care Medicine, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, People’s Republic of China",
    "Laboratory for Clinical Medicine, Capital Medical University, Beijing, 100069, People’s Republic of China",
    "Beijing Research Center for Respiratory Infectious Diseases, Beijing, 100069, People’s Republic of China"
  ],
  "article_type": "research article",
  "arxiv": null,
  "author_total": 4,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Yu Wang",
      "orcid": "0009-0008-2822-2488"
    },
    {
      "affs": [
        0
      ],
      "name": "Caopei Zheng",
      "orcid": "0000-0002-3138-6722"
    },
    {
      "affs": [
        0
      ],
      "name": "Yuqing Sun"
    },
    {
      "affs": [
        0,
        1,
        2
      ],
      "name": "Yulin Zhang",
      "orcid": "0000-0002-1214-594X"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/6nz75m3eb5tkq.bib",
  "cited_by": 0,
  "doi": "10.2147/idr.s638117",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13755821/",
  "id": "6nz75m3eb5tkq",
  "issns": [
    "1178-6973"
  ],
  "landing_url": "https://doi.org/10.2147/idr.s638117",
  "language": "en",
  "licence": "CC-BY-NC-4.0",
  "licence_label": "CC BY-NC 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by-nc/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Original Research"
    ],
    [
      "openalex",
      "2713|Pneumocystis jirovecii pneumonia detection and treatment"
    ]
  ],
  "openalex": "W7225420184",
  "pdf_url": "https://www.dovepress.com/article/download/121994",
  "pmcid": "PMC13755821",
  "pmid": "43022490",
  "published": "2026-11-07",
  "publisher": "Dove Press",
  "ris": "https://research.draconitic.com/paper/6nz75m3eb5tkq.ris",
  "sources": [
    {
      "first_seen": "2026-11-16T12:21:49Z",
      "native_id": "PMC13755821",
      "source": "pmc",
      "url": "https://doi.org/10.2147/idr.s638117"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2713|Pneumocystis jirovecii pneumonia detection and treatment",
      "subfield": "epidemiology-public-health"
    }
  ],
  "title": "Clinical Outcomes of Trimethoprim-Sulfamethoxazole with or Without Adjunctive Caspofungin in Patients with Moderate-to-Severe HIV-Associated Pneumocystis jirovecii Pneumonia: A Retrospective Cohort Study",
  "title_text": "Clinical Outcomes of Trimethoprim-Sulfamethoxazole with or Without Adjunctive Caspofungin in Patients with Moderate-to-Severe HIV-Associated Pneumocystis jirovecii Pneumonia: A Retrospective Cohort Study",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T12:21:49Z",
  "url": "https://research.draconitic.com/paper/6nz75m3eb5tkq",
  "venue": "Infection and Drug Resistance",
  "versions": []
}